GlassScriptPhysician profile
Philip D Greenberg
NPI 1801971635
$64,721.95
in general payments reported to CMS, 2019-2025
3 companies · $1,473 in 2025
The $1,473 reported for 2025 was more than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56K · 2023: $2,662 · 2024: $4,337 · 2025: $1,473.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $5,810 · Consulting Fee: $2,280 · Travel and Lodging: $306 · Food and Beverage: $76.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $5,810.17 |
| Consulting Fee | $2,280.00 |
| Travel and Lodging | $305.58 |
| Food and Beverage | $76.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $56,250.00 | 2019 | |
| Abbvie INC. | $5,810.17 | 2024-2025 | |
| Genentech USA, INC. | $2,661.78 | 2023 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Greenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.